Fig. 1
Heat map of the prevalence of adverse events from low-dose GCs per system/organ class, as estimated by rheumatologists

Heat map of the prevalence of adverse events from low-dose GCs per system/organ class, as estimated by rheumatologists

Numbers in each cell indicate the percentage of rheumatologists estimating a certain prevalence, and each row adds up to 100%. GCs: glucocorticoids.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close